USPTO serial 74318833
AMRAD
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 26, 1993
- Examiner
- NASH, LAURA
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with AMRAD?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Kew, Victoria, 3101, AU
Kew, Victoria, 3101, AU
Kew, Victoria, 3101, AU
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
James M. Slattery
JAMES M SLATTERY BIRCH, STEWART, KOLASCH & BIRCHP O BOX 747FALLS CHURCH, VA 22040-0747UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | chemical preparations used in industry and science; namely, proteinaceous reagents for use in maintaining embryos in culture, increasing embryo implantation, and capture and isolation of DNA; molecular biological reagents for use in the detection of nucleic acid sequences in-vitro and for the expression, isolation and detection of recombinant proteins; and antibody reagents and antibodies for use in detecting autoimmune disease, microbial disease, protein levels, genetic abnormalities and pathogens | SECTION 8 - CANCELLED | — |
| 005 | pharmaceutical preparations for human and veterinary use in the treatment of blood disorders, viral disease, nervous system disfunction, cancer, bone disease, liver disease, cardiac disorders, infertility, pregnancy disorders and inflammation; ELISA kits comprised of microtitre plates coated with antigen or antibody, positive serum control, negative serum control, specimen diluent, biotin antibody conjugates, biotin antibody diluents, streptavidin HRPO conjugates, streptavidin HRPO diluents, substrates, buffer solutions, wash buffers, stopping solutions and plate sealers for the detection of autoimmune disease, microbial disease, protein levels, genetic abnormalities and pathogens | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by AMRAD CORPORATION LTD
- Other trademarks owned by AMRAD CORPORATION LTD
- Other trademarks owned by AMRAD CORPORATION LTD
- Other trademarks in Class 001
- Other trademarks in Class 005
- Similar marks named AMRAD
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 23, 2000 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Oct 26, 1993 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 3, 1993 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 2, 1993 | NPUB | NOTICE OF PUBLICATION | — |
| May 17, 1993 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 27, 1993 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 29, 1992 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 8, 1992 | DOCK | ASSIGNED TO EXAMINER | — |